Mokslininku g. 12
Sanobiotec unites companies working in the field of novel medicinal and therapeutic compound research. Our core business is development, production and B2B sales of major and minor cannabinoids. At Sanobiotec, we are committed to cannabinoid research and development for a broad range of applications in the pharmaceutical and wellness industries. Our portfolio includes both mainstream and rare cannabinoids, including the sought-after THCV, CBN, CBC and CBDV, and a significant IP collection which also covers patentable processes. The combination of synthesis, biosynthesis and extraction capabilities enables the development of optimal production methods for each compound, leading to superior quality and efficiency.